These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 20179578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL, Siekmann J, Schwarz HP.
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO, Van Cott EM.
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
    Cabrera N, Moret A, Caunedo P, Cid AR, Vila V, España F, Aznar JA.
    Haemophilia; 2013 Nov; 19(6):920-5. PubMed ID: 23730809
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ, Thom J, Patterson D, Just S, Baccala M, Dixon T, Meiring M, Koutts J, Rowell J, Baker R.
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [Abstract] [Full Text] [Related]

  • 15. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M, Kimura A, Chiba Y, Yoshida Y.
    Thromb Haemost; 1988 Jun 16; 59(3):485-90. PubMed ID: 3142084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U, Pieconka A, Will K, Schneppenheim R.
    Semin Thromb Hemost; 2006 Jul 16; 32(5):514-21. PubMed ID: 16862525
    [Abstract] [Full Text] [Related]

  • 18. Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities.
    Chang P, Aronson DL.
    Thromb Haemost; 1997 Aug 16; 78(2):930-3. PubMed ID: 9268197
    [Abstract] [Full Text] [Related]

  • 19. von Willebrand factor standards for plasma and concentrate testing.
    Hubbard AR.
    Semin Thromb Hemost; 2006 Jul 16; 32(5):522-8. PubMed ID: 16862526
    [Abstract] [Full Text] [Related]

  • 20. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry.
    Sagheer S, Rodgers S, Yacoub O, Dauer R, Mcrae S, Duncan E.
    Haemophilia; 2016 May 16; 22(3):e200-7. PubMed ID: 27076201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.